Swiss clinical-stage radiopharmaceutical company Nuclidium completed a Series B financing round, raising CHF 79 million (EUR 84 million). Vischer advised Nuclidium throughout the operation, while Walder Wyss advised Angelini Ventures, Kurma Partners and Wellington Partners, in connection
Tags :Wellington Partners
Vischer advised the co-lead and other new investors in Aktiia’s oversubscribed USD 42m Series-B funding-round. Pursuant to the transaction, the blood pressure intelligence platform reached a total funding of USD 100m to date. The
